JPWO2021127586A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021127586A5 JPWO2021127586A5 JP2022538068A JP2022538068A JPWO2021127586A5 JP WO2021127586 A5 JPWO2021127586 A5 JP WO2021127586A5 JP 2022538068 A JP2022538068 A JP 2022538068A JP 2022538068 A JP2022538068 A JP 2022538068A JP WO2021127586 A5 JPWO2021127586 A5 JP WO2021127586A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- bond
- pharmaceutically acceptable
- acceptable salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962952161P | 2019-12-20 | 2019-12-20 | |
| US201962952097P | 2019-12-20 | 2019-12-20 | |
| US62/952,161 | 2019-12-20 | ||
| US62/952,097 | 2019-12-20 | ||
| US202063121721P | 2020-12-04 | 2020-12-04 | |
| US63/121,721 | 2020-12-04 | ||
| US202063125937P | 2020-12-15 | 2020-12-15 | |
| US63/125,937 | 2020-12-15 | ||
| PCT/US2020/066243 WO2021127586A1 (en) | 2019-12-20 | 2020-12-18 | Protein tyrosine phosphatase degraders and methods of use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023508914A JP2023508914A (ja) | 2023-03-06 |
| JP2023508914A5 JP2023508914A5 (https=) | 2023-12-25 |
| JPWO2021127586A5 true JPWO2021127586A5 (https=) | 2023-12-25 |
| JP7828893B2 JP7828893B2 (ja) | 2026-03-12 |
Family
ID=74206162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538068A Active JP7828893B2 (ja) | 2019-12-20 | 2020-12-18 | プロテインチロシンホスファターゼ分解剤及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240383886A1 (https=) |
| EP (1) | EP4077319A1 (https=) |
| JP (1) | JP7828893B2 (https=) |
| CN (1) | CN116194453A (https=) |
| AU (1) | AU2020407244A1 (https=) |
| CA (1) | CA3162364A1 (https=) |
| TW (1) | TWI879854B (https=) |
| UY (1) | UY38999A (https=) |
| WO (1) | WO2021127586A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120172958A (zh) | 2019-04-12 | 2025-06-20 | C4医药公司 | Ikaros和aiolos的三环降解物 |
| JP2023506227A (ja) | 2019-12-12 | 2023-02-15 | カムクワット バイオサイエンシーズ インコーポレイテッド | 免疫活性を強化するための組成物および方法 |
| WO2021222542A1 (en) * | 2020-04-30 | 2021-11-04 | President And Fellows Of Harvard College | 5-amino-2-piperidinon-3-yl-1-oxoisoindoline derivatives for degradation of ikzf2 degraders |
| IL302038A (en) * | 2020-10-14 | 2023-06-01 | C4 Therapeutics Inc | Tricyclic ligands for degradation of ikzf2 or ikzf4 |
| EP4228625A4 (en) * | 2020-10-14 | 2026-01-14 | C4 Therapeutics Inc | TRICYCLIC HETEROBFUNCTIONAL COMPOUNDS FOR TARGETED PROTEIN DEGRADATION |
| CN116457339A (zh) * | 2020-10-14 | 2023-07-18 | C4医药公司 | 用于医学治疗的降解新底物的三环化合物 |
| WO2022161414A1 (zh) * | 2021-01-26 | 2022-08-04 | 成都茵创园医药科技有限公司 | 芳香化合物、含其的药物组合物及其应用 |
| KR20240017814A (ko) | 2021-05-05 | 2024-02-08 | 바이오젠 엠에이 인코포레이티드 | 브루톤 티로신 키나제의 분해를 표적으로 하는 화합물 |
| WO2022271727A1 (en) * | 2021-06-21 | 2022-12-29 | Calico Life Sciences Llc | Degrader compounds and uses thereof |
| KR20240035526A (ko) | 2021-07-07 | 2024-03-15 | 바이오젠 엠에이 인코포레이티드 | Irak4 단백질의 분해를 표적하는 화합물 |
| AU2022326553A1 (en) * | 2021-08-10 | 2024-03-28 | Abbvie Inc. | Protein tyrosine phosphatase targeting ligands |
| CN118201923A (zh) * | 2021-10-15 | 2024-06-14 | 海南先声再明医药股份有限公司 | 三环类化合物 |
| TW202333670A (zh) * | 2022-01-04 | 2023-09-01 | 大陸商海思科醫藥集團股份有限公司 | 抑制並降解irak4的化合物及其藥物组合物和藥學上的應用 |
| MA69177B1 (fr) * | 2022-06-06 | 2026-03-31 | Treeline Biosciences, Inc. | Agents de dégradation bifonctionnels de quinolone-bcl6 tricycliques |
| CN120981456A (zh) | 2023-05-24 | 2025-11-18 | 金橘生物科技公司 | 杂环化合物及其用途 |
| KR20260040037A (ko) | 2023-07-14 | 2026-03-23 | 카톨리에케 유니버시테이트 루벤 | 암 및 대사 질병의 치료를 위한 신규 화합물 |
| TW202535389A (zh) | 2023-10-18 | 2025-09-16 | 香港商北嶺健康集團(香港)有限公司 | Ｐｔｐｎ２／ｐｔｐ１ｂ降解劑及其治療方法 |
| CN117343052B (zh) * | 2023-12-04 | 2024-02-06 | 英矽智能科技(上海)有限公司 | 蛋白酪氨酸磷酸酶抑制剂及其应用 |
| US12565492B2 (en) | 2024-08-09 | 2026-03-03 | Triana Biomedicines, Inc. | Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| AR066820A1 (es) * | 2007-06-04 | 2009-09-16 | Novartis Ag | Compuestos de tiadiazolidin-3 ona |
| CN109641874A (zh) | 2016-05-10 | 2019-04-16 | C4医药公司 | 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体 |
| EP3535254A4 (en) | 2016-11-01 | 2020-06-24 | Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") | COMPOUNDS FOR THE DEGRADATION OF MALT1 |
| EP4717317A2 (en) | 2017-06-20 | 2026-04-01 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| MX2020003190A (es) * | 2017-09-22 | 2020-11-11 | Kymera Therapeutics Inc | Degradadores de proteinas y usos de los mismos. |
| IL315310A (en) | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
-
2020
- 2020-12-18 US US17/787,828 patent/US20240383886A1/en active Pending
- 2020-12-18 WO PCT/US2020/066243 patent/WO2021127586A1/en not_active Ceased
- 2020-12-18 CN CN202080097241.6A patent/CN116194453A/zh active Pending
- 2020-12-18 EP EP20845470.2A patent/EP4077319A1/en active Pending
- 2020-12-18 CA CA3162364A patent/CA3162364A1/en active Pending
- 2020-12-18 AU AU2020407244A patent/AU2020407244A1/en active Pending
- 2020-12-18 JP JP2022538068A patent/JP7828893B2/ja active Active
- 2020-12-21 UY UY0001038999A patent/UY38999A/es unknown
- 2020-12-21 TW TW109145346A patent/TWI879854B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021127586A5 (https=) | ||
| JP7260718B2 (ja) | ジアザインドール誘導体及びそのＣｈｋ１阻害剤としての使用 | |
| JP3927630B2 (ja) | ウイルス感染症の予防・治療剤 | |
| JP2021534124A5 (https=) | ||
| US3574843A (en) | 1,4-dihydropyridine derivatives for the treatment of angina pectoris | |
| TWI257926B (en) | Novel 1,2,4-triazole compounds | |
| ES2281565T3 (es) | Inhibidores de la integrasa de vih de tipo dihidroxipirimidina carboxamida. | |
| TW444013B (en) | Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia | |
| AU2009234978B2 (en) | Acylthiourea Compound or Salt Thereof, and use thereof | |
| JP2018520195A5 (https=) | ||
| TW200303860A (en) | New compounds | |
| RU2125565C1 (ru) | Производные фенокси- или феноксиалкилпиперидина и антивирусная композиция на их основе | |
| JPWO2021023154A5 (https=) | ||
| JP2018511631A5 (https=) | ||
| JPWO2020123827A5 (https=) | ||
| WO2009114994A1 (zh) | 哒嗪酮类化合物在制备抗肿瘤药物中的用途 | |
| JPS59501409A (ja) | ピリドン化合物 | |
| JPWO2019148044A5 (https=) | ||
| FR2943669A1 (fr) | Derives de nicotinamide,leur preparation et leur application en therapeutique | |
| CN113396149A (zh) | Trex1的调节剂 | |
| JP2020534264A5 (https=) | ||
| BRPI0417193B1 (pt) | antibióticos híbridos de oxazolidinona-quinolona, seus sais monossódicos, dissódicos ou trissódicos e seus pró-fármacos, composições farmacêuticas, e seu uso | |
| JP2022522312A (ja) | ピロール化合物 | |
| RU2004118423A (ru) | Производные бензотиазола в качестве лигандов рецептора аденозина | |
| JP7587300B2 (ja) | Ｄｒｐ１－フィラミン複合体形成阻害剤 |